Abstract:The devastating effect of cancer is a worldwide concern. Unfortunately current chemotherapeutic and radio therapeutic modalities have been found to possess side effects coupled with the emergence of drug resistance. This has necessitated the search for novel therapeutic products with better efficacy, safety and affordability through identification of anti-tumor agents from natural products. In this study the antineoplastic activity and phytochemical screening of methanol extracts of four medicinal plants that are native to Lake Victoria Basin, including Piptadiniastrum africanum, Kigelia africana, Centella asciatica and Chaemocrista nigricans was investigated. Extraction and concentration of the collected and dried plant samples to obtain crude extracts as well as phytochemical screening of the crude extracts was done following standard procedures. Lung adenocarcinoma cell line, from American type cell culture (ATCC), was exposed to the extracts and antiproliferative analysis using 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2-tetrazolium bromide (MTT) colorimetric assay was performed. Phytochemical analysis of each of the four plants showed presence of terpenoids, alkaloids, saponins, tannins and steroids. Steroids were higher in the bark of P. africanum and the fruits of K. africana. Flavonoid was absent only in extracts of C. nigricans and coumarins present only in the extracts of K. africana. The methanolic extracts of the fruits of K. africana, bark of P. africanum, leaves of C. asciatica and leaves C. nigricans had inhibitory effects with IC50 28.86 ug/ml, 26.57 ug/ml, 15.69 ug/ml and 8.07 ug/ml (p values of 0.079, 0.069, and 0.042 and 0.055, ANOVA) respectively. Statistical differences among fractions of the extract were determined by one way ANOVA and considered significant at P<0.05. The MTT assay results indicated that all of the extracts had the capacity to inhibit the proliferation of tumor cells. The Phytochemical compounds which were tested are antioxidant and shown to trigger morphological changes, such as blebbing pattern and cell shrinkage, associated with apoptosis in the lung adenocarcinoma cell lines. The varying inhibitory activities against tested human lung adenocarcinoma cell lines justify the traditional use of these plants in the management of cancers and other illnesses. These extracts have a potential to be further developed into anti-tumor agents. However, further phytochemical characterization of the extracts is necessary for more extensive biological evaluation of the active ingredients and to exhaustively describe the mechanisms of cancer cell apoptosis of these four plant extracts.

Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines

Exploring various extracts and compounds of Grewia velutina as potential anticancer Agents: An in vitro and in silico investigations

Screening of plant collection of Cibodas Botanic Gardens, Indonesia with anticancer properties

Assessment of Anti-Proliferative Activities of Selected Medicinal Plant Extracts Used for Management of Diseases around Lake Victoria Basin

The Cytotoxic Activity and Metabolic Profiling of Hyptis rhomboidea Mart. et Gal

Cytotoxic and pro-apoptotic effects of botanical drugs derived from the indigenous cultivated medicinal plant Paris polyphylla var. yunnanensis

Evaluation of Indonesian mangrove Xylocarpus granatum leaves ethyl acetate extract as potential anticancer drug

Phytochemical Analysis and Anticancer Properties of Drimia maritima Bulb Extracts on Colorectal Cancer Cells

Anticancer Drug Discovery from Microbial Sources: The Unique Mangrove Streptomycetes

Untargeted metabolomics using UHPLC‐Q‐Orbitrap HRMS for identifying cytotoxic compounds on MCF‐7 breast cancer cells from Annona muricata Linn leaf extracts as potential anticancer agents

Identification of novel AKT1 inhibitors from Sapria himalayana bioactive compounds using structure-based virtual screening and molecular dynamics simulations

Potential Anti-Tumorigenic Properties of Diverse Medicinal Plants against the Majority of Common Types of Cancer

Dalbergia sissoo phytochemicals as EGFR inhibitors: an in vitro and in silico approach

Molecular Mechanism of Inhibition of Cell Proliferation: An In Silico Study of the Active Compounds in Curcuma longa as an Anticancer

Lead Phytochemicals for Anticancer Drug Development

Plant-based natural products in cancer therapeutics

Integrated Pharmacognostic and Computational Analysis of Hydrocotyle javanica Thunb. Phytochemicals as a Potential HER2 Tyrosine Kinase Inhibitor in Breast Cancer

Sclerocarya birrea and Terminalia prunioides : Phytochemical screening and synergistic inhibition of cervical cancer cells proliferation through modulation of EGFR, VEGF, MACC1, CYFRA 21-1, and CD 95 gene expressions

Phytochemical Screening, HPTLC Fingerprinting and Evaluation of In Vitro Cytotoxic Activity of Stem Bark Extracts of O roxylum indicum (L.) Vent. Against Human Cervical Cancer Cells

Unveiling the anticancer potential of Anamirta cocculus (L.) Wight& Arn.: Evidences from cytotoxicity studies, apoptosis analysis, and molecular docking

In vitro antioxidant, anticancer and in silico studies of polyphenol enriched leaf extract of Asystasia gangetica